National assessment of HPV and Pap tests: Changes in cervical cancer screening, National Health Interview Survey

Preventive Medicine
Meg WatsonMona Saraiya

Abstract

Major organizations recommend cytology screening (Pap test) every 3years for women aged 21-65; women aged 30 to 65 have the option of adding the HPV test (co-test) every 5years. We examined national percentages of cervical cancer screening, and we examined use of co-testing as an option for screening. We used 2015 U.S. National Health Interview Survey (NHIS) data to examine recent cervical cancer screening (Pap test within 3years among women aged 21-65 without a hysterectomy; N=10,596) and co-testing (N=9,125). We also conducted a multivariable analysis to determine odds of having had a Pap test or co-test by demographic variables. To evaluate changes in screening over time, we examined Pap testing during the years 2000, 2005, 2008, 2010, 2013 and 2015. Analysis completed in Atlanta, GA during 2016. Overall, 81.1% of eligible women reported having a Pap test within 3years; percentages declined over time among all age groups. An estimated 14 million women aged 21-65 had not been screened within the past 3years. Recent immigrants to the United States, women without insurance, and women without a usual source of healthcare had lower odds of being up to date with screening. About 1/3 of women up to date on Pap testing reported havi...Continue Reading

References

Dec 8, 2007·Journal of Women's Health·Jennifer TsuiLisa Richardson
Apr 3, 2008·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Garth H RauscherJennifer A Walk
Aug 12, 2009·Journal of Pain & Palliative Care Pharmacotherapy·UNKNOWN U.S. Food and Drug Administration
Jul 12, 2013·American Journal of Epidemiology·Ana Cecilia RodríguezUNKNOWN CVT Group
Nov 9, 2014·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Talía MalagónMarc Brisson
Dec 4, 2015·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Mariam El-ZeinEduardo L Franco
Sep 24, 2016·Obstetrics and Gynecology·UNKNOWN Committee on Practice Bulletins—Gynecology
Oct 27, 2016·American Journal of Obstetrics and Gynecology·Chun ChaoVirginia P Quinn
Mar 3, 2017·MMWR. Morbidity and Mortality Weekly Report·Arica WhiteLisa C Richardson

❮ Previous
Next ❯

Citations

Feb 24, 2018·Journal of Lower Genital Tract Disease·Laura R DailyCharles A Leath
Nov 20, 2018·CA: a Cancer Journal for Clinicians·Richard C WenderRobert A Smith
Jan 8, 2019·Journal of Women's Health·Kathy L MacLaughlinLila J Finney Rutten
Jan 9, 2019·CA: a Cancer Journal for Clinicians·Rebecca L SiegelAhmedin Jemal
Apr 14, 2019·International Journal of Cancer. Journal International Du Cancer·Angela A ClevelandUNKNOWN HPV-IMPACT Working Group
Aug 2, 2019·Expert Review of Molecular Diagnostics·Kathryn A KundrodRebecca Richards-Kortum
Aug 20, 2019·Journal of Community Health·Corley Rachelle PriceEduardo Gonzalez
Jun 24, 2020·Liver International : Official Journal of the International Association for the Study of the Liver·Tommaso Lorenzo Parigi, Alessio Aghemo
Jul 31, 2020·CA: a Cancer Journal for Clinicians·Elizabeth T H FonthamRobert A Smith
Nov 14, 2018·European Journal of Cancer Care·Senay Karadag ArliGulpinar Aslan
Jul 27, 2018·Preventing Chronic Disease·Ingrid J HallNancy Breen
Sep 27, 2020·Pharmacy : Journal of Pharmacy, Education and Practice·Madeline MitchellSally Rafie
Aug 25, 2020·Journal of the National Cancer Institute·Ashish A DeshmukhKalyani Sonawane
Nov 20, 2020·American Journal of Public Health·Natalie Privett, Shanice Guerrier
Dec 17, 2020·CA: a Cancer Journal for Clinicians·Lynne W ElmoreWilliam C Phelps
Apr 5, 2019·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Ann Goding SauerStacey A Fedewa
May 28, 2020·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Caitlin B BiddellLisa P Spees
Feb 23, 2019·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Nancy M McClungUNKNOWN HPV-IMPACT Working Group
Mar 9, 2020·European Journal of Obstetrics, Gynecology, and Reproductive Biology·Jose CarugnoMary Mackenzie Grady
Oct 12, 2018·Gynecologic Oncology·David K GaffneyTheresa L Werner
May 15, 2021·Journal of General Internal Medicine·Xuan ZhuLila J Finney Rutten
Apr 3, 2021·Journal of Lower Genital Tract Disease·Angela A ClevelandUNKNOWN HPV-IMPACT Working Group
Jul 15, 2021·Preventive Medicine Reports·Jennifer S HaasJasmin A Tiro
Jul 14, 2021·Gynecologic Oncology·Jack CuzickUNKNOWN New Mexico HPV Pap Registry Steering Committee
Sep 11, 2021·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Jennifer C SpencerStephanie B Wheeler
Sep 1, 2021·Journal of the National Cancer Institute·Philip E CastleUNKNOWN New Mexico HPV Pap Registry Steering Committee

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.